Literature DB >> 15627062

Immunohistochemical analysis of S6K1 and S6K2 localization in human breast tumors.

Valeriy V Filonenko1, Ruslana Tytarenko, Sergey K Azatjan, Lilya O Savinska, Yuriy A Gaydar, Ivan T Gout, Vasiliy S Usenko, Valeriy V Lyzogubov.   

Abstract

AIM: To perform an immunohistochemical analysis of human breast adenomas and adenocarcinomas as well as normal breast tissues in respect of S6 ribosomal protein kinase (S6K) expression and localization in normal and transformed cells.
METHODS: The expression level and localization of S6K have been detected in formalin fixed, paraffin embedded sections of normal human breast tissues, adenomas and adenocarcinomas with different grade of differentiation. Immunohistochemical detection of S6K1 and S6K2 in normal human breast tissues and breast tumors were performed using specific monoclonal and polyclonal antibodies against S6K1 and S6K2 with following semiquantitative analysis.
RESULTS: The increase of S6K content in the cytoplasm of epithelial cells in benign and malignant tumors has been detected. Nuclear accumulation of S6K1 and to a greater extend S6K2 have been found in breast adenocarcinomas. About 80% of breast adenocarcinomas cases revealed S6K2 nuclear staining comparing to normal tissues. In 31% of cases more then 50% of cancer cells had strong nuclear staining. Accumulation of S6K1 in the nucleus of neoplastic cells has been demonstrated in 25% of cases. Nuclear localization of S6K in the epithelial cells in normal breast tissues has not been detected.
CONCLUSION: Immunohistochemical analysis of S6K1 and S6K2 expression in normal human breast tissues, benign and malignant breast tumors clearly indicates that both kinases are overexpressed in breast tumors. Semiquantitative analysis of peculiarities of S6K localization in normal tissues and tumors revealed that nucleoplasmic accumulation of S6K (especially S6K2) is a distinguishing feature of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15627062

Source DB:  PubMed          Journal:  Exp Oncol        ISSN: 1812-9269


  16 in total

1.  Unique and Redundant Functions of p70 Ribosomal S6 Kinase Isoforms Regulate Mesenchymal Cell Proliferation and Migration in Pulmonary Fibrosis.

Authors:  Satish K Madala; Vishwaraj Sontake; Ramakrishna Edukulla; Cynthia R Davidson; Stephanie Schmidt; William D Hardie
Journal:  Am J Respir Cell Mol Biol       Date:  2016-12       Impact factor: 6.914

2.  Identification of S6K2 as a centrosome-located kinase.

Authors:  Rossella Rossi; John M Pester; Mitch McDowell; Samuela Soza; Alessandra Montecucco; Kay K Lee-Fruman
Journal:  FEBS Lett       Date:  2007-07-30       Impact factor: 4.124

3.  Differential expression of S6K2 dictates tissue-specific requirement for S6K1 in mediating aberrant mTORC1 signaling and tumorigenesis.

Authors:  Caterina Nardella; Andrea Lunardi; Giuseppe Fedele; John G Clohessy; Andrea Alimonti; Sara C Kozma; George Thomas; Massimo Loda; Pier Paolo Pandolfi
Journal:  Cancer Res       Date:  2011-03-28       Impact factor: 12.701

4.  Involvement of heterogeneous ribonucleoprotein F in the regulation of cell proliferation via the mammalian target of rapamycin/S6 kinase 2 pathway.

Authors:  Eddy T H Goh; Olivier E Pardo; Nicholas Michael; Andrew Niewiarowski; Nick Totty; Dariya Volkova; Irina R Tsaneva; Michael J Seckl; Ivan Gout
Journal:  J Biol Chem       Date:  2010-03-22       Impact factor: 5.157

5.  Context-Specific Function of S6K2 in Th Cell Differentiation.

Authors:  Christine Pai; Craig M Walsh; David A Fruman
Journal:  J Immunol       Date:  2016-09-09       Impact factor: 5.422

6.  Identification of a Dual Inhibitor of Janus Kinase 2 (JAK2) and p70 Ribosomal S6 Kinase1 (S6K1) Pathways.

Authors:  Sanguine Byun; Semi Lim; Ji Young Mun; Ki Hyun Kim; Timothy R Ramadhar; Lee Farrand; Seung Ho Shin; N R Thimmegowda; Hyong Joo Lee; David A Frank; Jon Clardy; Sam W Lee; Ki Won Lee
Journal:  J Biol Chem       Date:  2015-08-04       Impact factor: 5.157

Review 7.  Role of "oncogenic nexus" of CIP2A in breast oncogenesis: how does it work?

Authors:  Pradip De; Jennifer H Carlson; Brian Leyland-Jones; Nandini Dey
Journal:  Am J Cancer Res       Date:  2015-08-15       Impact factor: 6.166

8.  Inhibition of p70S6K2 down-regulates Hedgehog/GLI pathway in non-small cell lung cancer cell lines.

Authors:  Shinji Mizuarai; Aki Kawagishi; Hidehito Kotani
Journal:  Mol Cancer       Date:  2009-07-06       Impact factor: 27.401

9.  S6K2: The Neglected S6 Kinase Family Member.

Authors:  Olivier E Pardo; Michael J Seckl
Journal:  Front Oncol       Date:  2013-07-24       Impact factor: 6.244

10.  Deregulation of the phosphatase, PP2A is a common event in breast cancer, predicting sensitivity to FTY720.

Authors:  Shawn Baldacchino; Christian Saliba; Vanessa Petroni; Anthony G Fenech; Nigel Borg; Godfrey Grech
Journal:  EPMA J       Date:  2014-01-25       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.